Large-scale, peer-reviewed study quantifies multiple devastating patient harms associated with blood culture contamination and most significantly, a 74% increase in risk of in-hospital patient mortality

/PRNewswire/ -- Magnolia Medical Technologies, Inc. ("Magnolia Medical"), inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®), the only FDA...

Related Keywords

Arkansas ,United States ,University Of Arkansas ,Little Rock ,Greg Bullington ,Antimicrobial Stewardship Program At University Of Arkansas ,Sciences Health ,Emergency Department ,National Email Update To Clinicians ,Clinical Laboratory ,Emergency Nurses Association ,Laboratory Standards Institute ,Prnewswire Magnolia Medical Technologies Inc ,Medical Technologies ,Initial Specimen Diversion ,Medical Sciences ,Medical Center ,Multidrug Resistant Organism ,Infection Control ,Hospital Epidemiology ,Body Mass Index ,Associate Professor ,Infectious Diseases Specialist ,Medical Director ,Antimicrobial Stewardship Program ,Culture Contamination Prevention Actions ,Antibiotic Stewardship Programs Working ,Nurses Association ,Specimen Diversion ,Control Hosp ,Magnolia Medical Technologies ,